Wakefield Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$536K Buy
+447
New +$457K 0.12% 187
2024
Q4
Sell
-4,247
Closed -$3.76M 160
2024
Q3
$3.76M Buy
4,247
+33
+0.8% +$29.7K 1.22% 24
2024
Q2
$3.82M Buy
+4,214
New +$3.37M 1.34% 17
2019
Q1
Sell
-230
Closed -$27K 229
2018
Q4
$27K Buy
+230
New +$25.7K 0.01% 181

Other funds holding LLY

Wakefield Asset Management's LLY Position: Q2 2026 in Review

Wakefield Asset Management opened a new position in Eli Lilly (LLY) in Q2 2026: 447 shares worth $536K. The stake represents 0.12% of the portfolio and ranks #187 among its holdings. This is a return to the name: Wakefield Asset Management previously reported a position in LLY as recently as Q3 2024.

Wakefield Asset Management first reported a position in LLY in Q4 2018 and has held it in 4 quarters since. The position peaked at $3.82M in Q2 2024. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Wakefield Asset Management held 447 shares of Eli Lilly worth $536K as of Q2 2026.
  • Eli Lilly was a new Wakefield Asset Management position in Q2 2026.
  • Eli Lilly made up 0.12% of Wakefield Asset Management's portfolio in Q2 2026, its #187 holding.
  • Wakefield Asset Management first reported a position in Eli Lilly in Q4 2018 and has held it in 4 quarters since.
  • Wakefield Asset Management's Eli Lilly position peaked at $3.82M in Q2 2024.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wakefield Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.